Potential of Dihydropyrimidine Dehydrogenase Genotypes in Personalizing 5-Fluorouracil Therapy Among Colorectal Cancer Patients

by Bannur, Z, Fijeraid, H, Hamzah, S, Hasbullani, Z, Hashim, H, Ngow, H, Nor, AM, Ramasamy, P, Salleh, MZ, Shia, JKS, Sood, S, Teh, LK, Zailani, M, Zakaria, ZA

Potential of dihydropyrimidine dehydrogenase genotypes in personalizing 5-fluorouracil therapy among colorectal cancer patients

by Bannur, Z., Fijeraid, H., Hamzah, S., Hasbullani, Z., Hashim, H., Md Nor, A., Ngow, H., Ramasamy, P., Salleh, M.Z, Shia, J.K.S, Sood, S., Teh, L.K, Zailani, M., Zakaria, Z.A

The risk of recurrence in breast cancer patients treated with tamoxifen: Polymorphisms of CYP2D6 and ABCB1

by Din, J., Henry, G., Hla U, K.T, Mohamed, N.I, Muniandy, S.P, Ngow, H.A, Rajoo, T.S, Rohaizak, M., Roslan, H., Saladina, J.J, Salleh, M.Z, Shahrun, N.S, Shia, J.K.S, Sood, S., Teh, L.K